Dr. A. Silvia Ross, M.D.
What this data tells you about Dr. Ross
Dr. A. Silvia Ross is an optician specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ross performed 248,650 Medicare services across 3,283 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ross received a total of $386,537 from 49 pharmaceutical and/or device companies across 1499 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 90,640 | $5 | $7 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
86,000 | $4 | $9 |
| Romosozumab injection (Evenity) for osteoporosis | 21,840 | $8 | $12 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
20,350 | $10 | $33 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
10,550 | $32 | $61 |
| Denosumab injection (Prolia/Xgeva) | 9,061 | $18 | $25 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,790 | $26 | $101 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,232 | $1 | $62 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
753 | $85 | $156 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
519 | $4 | $25 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
501 | $5 | $46 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
449 | $8 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
444 | $10 | $20 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
437 | $39 | $163 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $60 | $121 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
347 | $16 | $73 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
314 | $46 | $170 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
300 | $96 | $251 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
235 | $6 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
182 | $127 | $207 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
171 | $21 | $84 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
160 | $11 | $71 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
130 | $29 | $65 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
124 | $1 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
101 | $8 | $11 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
73 | $5 | $28 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
63 | $4 | $35 |
| Liver function blood test panel | 60 | $8 | $60 |
| New patient office visit, complex (60-74 min) | 60 | $153 | $297 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
56 | $5 | $24 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
52 | $45 | $127 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
48 | $11 | $30 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
39 | $35 | $210 |
| Kidney function blood test panel | 30 | $9 | $60 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
28 | $4 | $42 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
25 | $34 | $89 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
25 | $13 | $30 |
| Rheumatoid factor level | 25 | $6 | $18 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $111 | $297 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
22 | $3 | $11 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $42 | $96 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
12 | $48 | $300 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in NC.
Geographic Context
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ross is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with speaking/promotional industry engagement in the top 1% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ross experienced with tocilizumab injection (actemra)?
Does Dr. Ross receive payments from pharmaceutical companies?
How do Dr. Ross's costs compare to other opticians in Raleigh?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology